Hemab Therapeutics Holdings, Inc. Common Stock (COAG) Earnings Analysis
Hemab Therapeutics Holdings, Inc. Common Stock (COAG) next reports earnings on 2026-08-20. In its last reported quarter (2026-05-21) COAG missed analyst consensus (-3.2% EPS surprise). Trailing P/E -21.13.
Last updated 2026-07-23 · Source: company filings + earnings calendar; consensus from sell-side analyst grades
When does COAG next report earnings?
| Next earnings date | 2026-08-20 |
|---|
COAG last-quarter earnings result
| Last reported quarter | 2026-05-21 |
|---|---|
| Result vs consensus | Miss (-3.2% EPS surprise) |
COAG consensus estimates and analyst view
Consensus estimates, 8-quarter history and analyst targets are in the SniperIQ app. Create a free account to see them.
Related research pages
More on COAG
Frequently asked questions
When does COAG next report earnings?
COAG is next scheduled to report earnings on 2026-08-20.
Did COAG beat earnings last quarter?
In its 2026-05-21 report, COAG missed analyst consensus (-3.2% EPS surprise).
Where can I see COAG analyst estimates and price targets?
Consensus estimates, 8-quarter history and analyst targets for COAG are in the SniperIQ app: https://app.sniperiq.ai/register